Interference Peak [Bioanalytics]

posted by Dr. Harish L. Rao – India, 2007-09-20 11:42 (6850 d 19:17 ago) – Posting: # 1096
Views: 7,498

(edited on 2007-09-20 11:56)

Dear Group Members,

During subject plasma sample analysis by LC/MS/MS, an extra peak (possibly due to metabolite) is observed which is not completely separated from the drug peak. But Method Validation was performed without the metabolite (as per OGD communication) & there was no interference peak during method validation. In such a situation, how should the analyst proceed with subject sample analysis?

Thanks & regards,
Dr. Harish L. Rao

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
124 visitors (0 registered, 124 guests [including 13 identified bots]).
Forum time: 07:00 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5